Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7358 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD7149 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD5680 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD5078 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD6357 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD3984 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD3983 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD6607 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD5600 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD1078 |
Clinical (unspecified phase) |
0.6976 |
Remote Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4986 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4796 |
Discontinued |
0.6957 |
Remote Similarity |
NPD8016 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD8403 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD8358 |
Approved |
0.6916 |
Remote Similarity |
NPD7222 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD5547 |
Clinical (unspecified phase) |
0.69 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD6861 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD5530 |
Phase 1 |
0.6856 |
Remote Similarity |
NPD19 |
Approved |
0.6856 |
Remote Similarity |
NPD1743 |
Approved |
0.6856 |
Remote Similarity |
NPD1742 |
Approved |
0.6816 |
Remote Similarity |
NPD5900 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD7034 |
Discontinued |
0.6798 |
Remote Similarity |
NPD5522 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.6777 |
Remote Similarity |
NPD7889 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD5521 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7877 |
Suspended |
0.6759 |
Remote Similarity |
NPD7453 |
Approved |
0.6759 |
Remote Similarity |
NPD7452 |
Approved |
0.6754 |
Remote Similarity |
NPD814 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD6738 |
Phase 2 |
0.6753 |
Remote Similarity |
NPD6737 |
Phase 2 |
0.6746 |
Remote Similarity |
NPD7262 |
Phase 1 |
0.6746 |
Remote Similarity |
NPD6046 |
Clinical (unspecified phase) |
0.6721 |
Remote Similarity |
NPD8363 |
Approved |
0.6721 |
Remote Similarity |
NPD8364 |
Approved |
0.6683 |
Remote Similarity |
NPD6281 |
Approved |
0.6683 |
Remote Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD5670 |
Approved |
0.6667 |
Remote Similarity |
NPD6526 |
Approved |
0.6667 |
Remote Similarity |
NPD4203 |
Approved |
0.6667 |
Remote Similarity |
NPD4204 |
Approved |
0.6667 |
Remote Similarity |
NPD4951 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6037 |
Discontinued |
0.6667 |
Remote Similarity |
NPD8365 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD1305 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD7671 |
Approved |
0.6651 |
Remote Similarity |
NPD7672 |
Approved |
0.6634 |
Remote Similarity |
NPD4354 |
Approved |
0.6627 |
Remote Similarity |
NPD8467 |
Approved |
0.6627 |
Remote Similarity |
NPD8427 |
Approved |
0.6627 |
Remote Similarity |
NPD8429 |
Approved |
0.6627 |
Remote Similarity |
NPD8466 |
Approved |
0.6627 |
Remote Similarity |
NPD8465 |
Approved |
0.6627 |
Remote Similarity |
NPD8428 |
Approved |
0.6625 |
Remote Similarity |
NPD6503 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD7676 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD7674 |
Phase 3 |
0.6623 |
Remote Similarity |
NPD7675 |
Phase 3 |
0.6622 |
Remote Similarity |
NPD7678 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD6340 |
Approved |
0.6618 |
Remote Similarity |
NPD6339 |
Approved |
0.6617 |
Remote Similarity |
NPD6365 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD7820 |
Phase 3 |
0.6606 |
Remote Similarity |
NPD7225 |
Discontinued |
0.6605 |
Remote Similarity |
NPD6592 |
Clinical (unspecified phase) |
0.6598 |
Remote Similarity |
NPD5617 |
Suspended |
0.6585 |
Remote Similarity |
NPD3037 |
Phase 1 |
0.6584 |
Remote Similarity |
NPD5938 |
Phase 3 |
0.6578 |
Remote Similarity |
NPD7194 |
Discontinued |
0.6575 |
Remote Similarity |
NPD5658 |
Approved |
0.6573 |
Remote Similarity |
NPD6527 |
Approved |
0.6564 |
Remote Similarity |
NPD7221 |
Approved |
0.6564 |
Remote Similarity |
NPD7219 |
Approved |
0.6564 |
Remote Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.656 |
Remote Similarity |
NPD7174 |
Clinical (unspecified phase) |
0.656 |
Remote Similarity |
NPD3003 |
Approved |
0.656 |
Remote Similarity |
NPD6150 |
Discontinued |
0.6558 |
Remote Similarity |
NPD6810 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD3810 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD4418 |
Discontinued |
0.6557 |
Remote Similarity |
NPD7686 |
Clinical (unspecified phase) |
0.6555 |
Remote Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD7796 |
Approved |
0.6552 |
Remote Similarity |
NPD7797 |
Approved |
0.6552 |
Remote Similarity |
NPD4498 |
Clinical (unspecified phase) |
0.6548 |
Remote Similarity |
NPD6063 |
Approved |
0.6547 |
Remote Similarity |
NPD6140 |
Clinical (unspecified phase) |
0.654 |
Remote Similarity |
NPD5587 |
Approved |
0.654 |
Remote Similarity |
NPD6569 |
Phase 2 |
0.6538 |
Remote Similarity |
NPD5256 |
Discontinued |
0.6526 |
Remote Similarity |
NPD8249 |
Clinical (unspecified phase) |
0.6526 |
Remote Similarity |
NPD3477 |
Phase 2 |
0.6526 |
Remote Similarity |
NPD3478 |
Clinical (unspecified phase) |
0.6523 |
Remote Similarity |
NPD8426 |
Approved |
0.6523 |
Remote Similarity |
NPD8425 |
Approved |
0.6523 |
Remote Similarity |
NPD8459 |
Approved |
0.6523 |
Remote Similarity |
NPD8460 |
Approved |
0.6522 |
Remote Similarity |
NPD3109 |
Approved |
0.6522 |
Remote Similarity |
NPD3110 |
Approved |
0.652 |
Remote Similarity |
NPD3503 |
Approved |
0.652 |
Remote Similarity |
NPD3504 |
Approved |
0.6514 |
Remote Similarity |
NPD31 |
Approved |
0.6514 |
Remote Similarity |
NPD4036 |
Approved |
0.6514 |
Remote Similarity |
NPD4039 |
Approved |
0.6514 |
Remote Similarity |
NPD4033 |
Approved |
0.6514 |
Remote Similarity |
NPD4035 |
Approved |
0.6514 |
Remote Similarity |
NPD4037 |
Approved |
0.6514 |
Remote Similarity |
NPD4122 |
Approved |
0.6514 |
Remote Similarity |
NPD32 |
Approved |
0.6514 |
Remote Similarity |
NPD4038 |
Approved |
0.6514 |
Remote Similarity |
NPD4034 |
Approved |
0.6512 |
Remote Similarity |
NPD6874 |
Approved |
0.6509 |
Remote Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD6976 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD1033 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD7821 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD1034 |
Phase 3 |
0.6505 |
Remote Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.6504 |
Remote Similarity |
NPD3763 |
Approved |
0.6502 |
Remote Similarity |
NPD7032 |
Approved |
0.6498 |
Remote Similarity |
NPD6208 |
Discontinued |
0.6495 |
Remote Similarity |
NPD5515 |
Phase 2 |
0.6495 |
Remote Similarity |
NPD8401 |
Approved |
0.6495 |
Remote Similarity |
NPD8402 |
Approved |
0.6495 |
Remote Similarity |
NPD8400 |
Approved |
0.649 |
Remote Similarity |
NPD7424 |
Clinical (unspecified phase) |
0.649 |
Remote Similarity |
NPD6021 |
Clinical (unspecified phase) |
0.649 |
Remote Similarity |
NPD6344 |
Clinical (unspecified phase) |
0.6488 |
Remote Similarity |
NPD3920 |
Phase 2 |
0.6486 |
Remote Similarity |
NPD6220 |
Phase 3 |
0.6484 |
Remote Similarity |
NPD6245 |
Phase 2 |
0.6479 |
Remote Similarity |
NPD6491 |
Clinical (unspecified phase) |
0.6479 |
Remote Similarity |
NPD6251 |
Discontinued |
0.6476 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6468 |
Remote Similarity |
NPD6991 |
Approved |
0.6468 |
Remote Similarity |
NPD6872 |
Clinical (unspecified phase) |
0.6468 |
Remote Similarity |
NPD6379 |
Discontinued |
0.6462 |
Remote Similarity |
NPD3924 |
Approved |
0.6462 |
Remote Similarity |
NPD3923 |
Approved |
0.6462 |
Remote Similarity |
NPD3921 |
Approved |
0.6462 |
Remote Similarity |
NPD5811 |
Approved |
0.6462 |
Remote Similarity |
NPD3922 |
Approved |
0.6456 |
Remote Similarity |
NPD6293 |
Clinical (unspecified phase) |
0.6452 |
Remote Similarity |
NPD6238 |
Discontinued |
0.645 |
Remote Similarity |
NPD6978 |
Phase 2 |
0.645 |
Remote Similarity |
NPD6977 |
Clinical (unspecified phase) |
0.6449 |
Remote Similarity |
NPD6550 |
Discontinued |
0.6445 |
Remote Similarity |
NPD3408 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD5083 |
Clinical (unspecified phase) |
0.6438 |
Remote Similarity |
NPD4795 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD5944 |
Phase 1 |
0.6429 |
Remote Similarity |
NPD6257 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD2383 |
Phase 1 |
0.6429 |
Remote Similarity |
NPD5945 |
Phase 1 |
0.6425 |
Remote Similarity |
NPD7020 |
Approved |
0.6425 |
Remote Similarity |
NPD7019 |
Approved |
0.6425 |
Remote Similarity |
NPD5845 |
Phase 2 |
0.6422 |
Remote Similarity |
NPD3515 |
Approved |
0.6422 |
Remote Similarity |
NPD6316 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD3516 |
Approved |
0.6419 |
Remote Similarity |
NPD8311 |
Discontinued |
0.6419 |
Remote Similarity |
NPD6769 |
Clinical (unspecified phase) |
0.6419 |
Remote Similarity |
NPD6284 |
Clinical (unspecified phase) |
0.6419 |
Remote Similarity |
NPD7238 |
Clinical (unspecified phase) |
0.6411 |
Remote Similarity |
NPD4889 |
Approved |
0.6404 |
Remote Similarity |
NPD4083 |
Discontinued |
0.6402 |
Remote Similarity |
NPD3324 |
Clinical (unspecified phase) |
0.6402 |
Remote Similarity |
NPD6590 |
Discontinued |
0.64 |
Remote Similarity |
NPD5903 |
Approved |
0.64 |
Remote Similarity |
NPD5902 |
Approved |
0.64 |
Remote Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.6398 |
Remote Similarity |
NPD3349 |
Phase 2 |
0.6396 |
Remote Similarity |
NPD2789 |
Approved |
0.6396 |
Remote Similarity |
NPD980 |
Clinical (unspecified phase) |
0.6395 |
Remote Similarity |
NPD7589 |
Clinical (unspecified phase) |
0.639 |
Remote Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.639 |
Remote Similarity |
NPD8359 |
Phase 2 |
0.6387 |
Remote Similarity |
NPD5754 |
Discontinued |
0.6387 |
Remote Similarity |
NPD6506 |
Clinical (unspecified phase) |
0.6386 |
Remote Similarity |
NPD6457 |
Approved |
0.6384 |
Remote Similarity |
NPD3816 |
Phase 1 |
0.6384 |
Remote Similarity |
NPD3815 |
Phase 1 |
0.6383 |
Remote Similarity |
NPD7558 |
Phase 2 |
0.6383 |
Remote Similarity |
NPD6741 |
Clinical (unspecified phase) |
0.6382 |
Remote Similarity |
NPD5599 |
Discontinued |
0.6381 |
Remote Similarity |
NPD5565 |
Discontinued |
0.6376 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.6375 |
Remote Similarity |
NPD6773 |
Clinical (unspecified phase) |
0.6372 |
Remote Similarity |
NPD8149 |
Discontinued |
0.6368
|
Remote Similarity |
NPD2843 |
Phase 2 |